Pro zobrazení tohoto obsahu je třeba být přihlášen.
Categories for Uncategorized
FINAL ANALYSIS OF THE AHL201 RANDOMIZED PHASE III LYSA STUDY COMPARING AN EARLY PET DRIVEN TREATMENT DE-ESCALATION TO A NOT PET-MONITORED STRATEGY IN PATIENTS WITH ADVANCED STAGES HODGKIN LYMPHOMA
27 ledna, 2021 8:38 pmAuthor(s): Olivier Casasnovas, Pauline Brice, Reda Bouabdallah, et. al Abstract: S110 Session topic: 17. Hodgkin lymphoma – Clinical...
PRETREATMENT VITAMIN D DEFICIENCY IS ASSOCIATED WITH LOWER PROGRESSION- -FREE AND OVERALL SURVIVAL IN PROSPECTIVELY TREATED HODGKIN LYMPHOMA
27 ledna, 2021 8:38 pmAuthor(s): Sven Borchmann, Helen Görgen, Stephanie Sasse, et. al. Abstract: S111 Session topic: 17. Hodgkin lymphoma – Clinical...
Nedostatok vitamínu D a znížené prežívanie pacientov s Hodgkinovým lymfómom
27 ledna, 2021 8:38 pmAutori tejto práce testovali hypotézu, či znížená hladina vitamínu D znižuje prežívanie bez progresie (PFS) a celkové prežívanie (OS) pacientov s Hodgkinovým...
RESULTS FROM 48-WEEK FOLLOW-UP OF THE EXPAND STUDY: A PHASE 1B, OPEN-LABEL, DOSE-FINDING STUDY OF RUXOLITINIB IN PATIENTS WITH MYELOFIBROSIS AND LOW PLATELET COUNTS (50-99 × 109/L) AT BASELINE
27 ledna, 2021 8:37 pmAuthor(s): Alessandro M. Vannucchi, Peter te Boekhorst, Claire N. Harrison, Guangsheng He, Marianna Caramella, Dietger Niederwieser, Françoise Boyer-Perrard, Minghui Duan,...
ARRAYED MOLECULAR BARCODING IDENTIFIES TNFSF13 AS A POSITIVE REGULATOR OF ACUTE MYELOID LEUKEMIA-INITIATING CELLS
27 ledna, 2021 8:37 pmAuthor(s): Marion Chapellier, Pablo Peña-Martínez, Ramprasad Ramakrishnan, Mia Eriksson, et al. Abstract: S815 Session topic: 3. Acute myeloid...
RESULTS OF PIVOTAL PHASE 2 TRIAL OF SL-401 IN PATIENTS WITH BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASM
27 ledna, 2021 8:37 pmAuthor(s): Naveen Pemmaraju, Kendra Sweet, Andrew Lane, Anthony Stein, et al. Abstract: S116 Session topic: 4. Acute myeloid...
AKUTNÍ MYELOIDNÍ LEUKEMIE – NOVINKY V DIAGNOSTICE A LÉČBĚ
27 ledna, 2021 8:37 pmKonference EHA 2018, konaná ve Stockholmu, se věnovala extenzivně oblasti preleukemických predispozičních stavů a dále vlivu stárnutí na patogenezi akutní myeloidní leukemie (AML)....
LONG-TERM SAFETY AND EFFICACY OF RITUXIMAB IN 248 ADULT IMMUNE THROMBOCYTOPENIA PATIENTS: RESULTS WITH MORE THAN 5 YEARS OF FOLLOW-UP FROM A FRENCH PROSPECTIVE REGISTRY ITP-RITUX
27 ledna, 2021 8:37 pmAuthor(s): Samuel Deshayes, Mehdi Khellaf, Anissa Zarour, et. al. Abstract: S141 Session topic: 33. Platelets disorders Background...
COMPARISON OF STANDARD- AND LOW-DOSE RITUXIMAB IN PRIMARY IMMUNE THROMBOCYTOPENIA (ITP): DATA FROM THE UK ITP REGISTRY
27 ledna, 2021 8:37 pmAuthor(s): Caitlin Gracie, Abbas Zaidi, Umesh Doobaree, et. al. Abstract: S139 Session topic: 33. Platelets disorders Background...
FACTORS AFFECTING THROMBOPOIETIN RECEPTOR AGONIST REINITIATION AFTER DISCONTINUATION IN WELL-CONTROLLED PATIENTS WITH IMMUNE THROMBOCYTOPENIA IN THE UK: RESULTS FROM A MODIFIED DELPHI CONSENSUS PANEL
27 ledna, 2021 8:37 pmAuthor(s): Nichola Cooper, Quentin Hill, John Grainger, et. al. Abstract: PS1411 Session topic: 33. Platelets disorders Background...